In Vivo Animal Models for Investigating Potential CYP3A- and Pgp-Mediated Drug-Drug Interactions

E-ISSN： 1875-5453|7|7|687-704

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.7, 2006-10, pp. : 687-704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S. Galetin Aleksandra Hallifax David Houston J. Brian

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 430-455

Bentham Science Publishers

Access to resources Recommend Favorite

Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions

By Tang Cuyue Prueksaritanont Thomayant

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1772-1787

Springer Publishing Company

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian Fromm Martin F

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite

Animal Models for Evaluation of Drug-Drug Interaction Potential of Biotherapeutics

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-01 ,pp. : 947-950

Bentham Science Publishers

Access to resources Recommend Favorite